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Infection-induced RBC dysfunction has been shown to play a role in the modulation of host response to injury and infection. The underlying
biochemical mechanisms are not known. This study investigated alterations in RBC band-3 phosphorylation status and its relationship to anion
exchange activity in vitro as well as under in vivo septic conditions induced by cecal ligation and puncture (CLP) in mice. Pervanadate treatment
in vitro increased band-3 tyrosine phosphorylation that was accompanied by decreased RBC deformability and anion exchange activity. Following
sepsis, band-3 tyrosine phosphorylation in whole RBC ghosts as well as in cytoskeleton-bound or soluble RBC protein fractions were elevated as
compared to controls. Although anion exchange activity was similar in RBCs from septic and control animals, band-3 interaction with eosin-5-
maleimide (EMA), which binds to band-3 lysine moieties, was increased in cells from septic animals as compared to controls, indicating that
sepsis altered band 3 organization within the RBC membrane. Since glucose-6-phosphate dehydrogenase is a major antioxidant enzyme in RBC,
in order to assess the potential role of oxidative stress in band-3 tyrosine phosphorylation, sepsis-induced RBC responses were also compared
between WT and (G6PD) mutant animals (20% of normal G6PD activity). Band-3 membrane content and EMA staining were elevated in G6PD
mutant mice compared to WT under control non-septic conditions. Following sepsis, G6PD mutant animals showed lessened responses in band-3
tyrosine phosphorylation and EMA staining compared to WT. RBC anion exchange activity was similar between mutant and WT animals under all
tested conditions. In summary, these studies indicate that sepsis results in elevated band-3 tyrosine phosphorylation and alters band-3 membrane
organization without grossly affecting RBC anion exchange activity. The observations also suggest that factors other than oxidative stress are
responsible for the sepsis-induced increase in RBC band-3 tyrosine phosphorylation.
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Infection-induced RBC dysfunction has been shown to play
an important role in the modulation of host response and may
contribute to organ dysfunction in septic patients [1–3]. During
inflammation, the alterations in RBC functions include
decreased RBC deformability [2,4], increased methemoglobin
content [5], cell aggregation [6] and augmented RBC attach-
ment to the endothelium and macrophages [7,8]. These RBC
alterations may contribute to microcirculatory dysfunction by
causing blood congestion and impair oxygen exchange under
septic conditions. However, the biochemical mechanisms⁎ Corresponding author. Tel.: +1 973 972 0117; fax: +1 973 972 6803.
E-mail address: spolaric@umdnj.edu (Z. Spolarics).
0925-4439/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2007.02.004responsible for RBC dysfunction following inflammation
have not been fully elucidated.
Band-3 is a multifunctional RBC membrane protein that
plays several important roles in RBC metabolism and
morphology. Band-3 membrane abundance and its organization
(dimers; tetramers) within the RBCmembrane have been shown
to be important for normal anion exchange activity, cytoskeletal
structure, cell shape and glycolytic activity [9–12]. In contrast,
changes in band-3 structure and its membrane organization had
been observed after oxidative stress or during physiological
aging of RBCs and was accompanied by cell shrinkage,
decreased cell deformability and alterations in RBC metabolic
activity [13–15]. Thus, band-3 is a potential molecular target in
sepsis, and alterations in band-3 may be associated with RBC
dysfunction during septic conditions.
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function is regulated by its phosphorylation status. Increased
band-3 tyrosine phosphorylation has been shown to stimulate
glycolysis [12,16] and alter the cytoskeletal organization by
modulating the interactions between band-3 and cytoskeletal
anchoring proteins [17–19]. Studies have also shown that
elevated band-3 phosphorylation alters its anion transport
activity [20–22]. Hemoglobinopathies have been shown to be
accompanied by elevated band-3 tyrosine phosphorylation
[23,24] however, it is largely unknown whether band-3
phosphorylation is altered during acute pathophysiological
challenges in vivo. Likewise, whereas it is well documented
that sepsis or endotoxemia causes RBC dysfunctions, alterations
in band-3 phosphorylation or functional status have not been
reported under these conditions.
Therefore, based on these observations, we hypothesized
that the RBC dysfunction observed during inflammation would
be associated with alterations in band-3 phosphorylation status.
To test this hypothesis, we employed a polymicrobial septic
model in which RBC dysfunctions, including decreased cell
deformability, is well documented [4,6,25,26]. Additionally, we
tested whether the sepsis-induced increase in band-3 tyrosine
phosphorylation is accompanied by alterations in RBC anion
transport activity. Furthermore, because oxidative stress has
been shown to play an important role in causing RBC
dysfunction during sepsis or endotoxemia, we also utilized a
glucose 6-phosphate dehydrogenase (G6PD) mutant mouse
model in which organ and cell responses display increased
sensitivity to oxidative stress [25,27,28].
2. Materials and methods
2.1. Animals
Male 12–15weeks oldWTandG6PDmutant mice from our breeding colony
at Taconic Farm (Germantown, NY) were used in the experiments. Animals were
phenotyped byG6PD activity in whole blood using a kit as well as by genotyping
as described in detail earlier [25,29]. The studies were performed in accordance
with the Guide for the Care and Use of Laboratory Animals [DHEW Publication
No. (NIH) 85-23, Revised 1985, Office of Science and Health Reports, DRR/
NIH, Bethesda, MD 20205] and were approved by the Institutional Animal Care
and Use Committee of the New Jersey Medical School.
2.2. Cecal ligation and puncture (CLP)
Polymicrobial sepsis was induced using the CLP model as described earlier
[30]. Briefly, animals were anesthetized by a subcutaneous injection of
Nembutal (5 mg/100 g bw). A midline abdominal incision was made. The
cecum was exposed, ligated and punctured with a 20-gauge needle in two
places. Animals were resuscitated by the subcutaneous injection of isotonic,
pyrogen-free saline solution (0.025 ml/g bw) postoperatively, and also at 22 h
post CLP. Blood was collected into heparinized tubes for analyses 24 h after the
surgical procedures. In this model, animals begin to expire at 24–30 h with an
overall mortality of 70% by 72–96 h. The 24-h sampling for the studies
prevented introducing survival bias in the studies.
2.3. Preparation of RBC suspensions, ghosts and sub-fractions
Fresh heparinized blood was centrifuged at 900×g for 10 min and the
plasma and buffy coat removed. To ensure removal of leukocytes and platelets
the packed red cells were washed 3 times with PBS containing 5.5 mM glucose
and 0.08% bovine serum albumin. At every washing step, the upper 1/5 volumeof the packed red cells was removed. The final RBC pellet was re-suspended to a
final hematocrit of 10% and used for experiments testing whole RBC responses.
For preparation of RBC ghosts, washed packed red blood cells were lysed
with ice cold 5 mM sodium phosphate buffer, pH 8.0, containing 1 mM EGTA,
1 mM sodium orthovanadate, and 1 mM phenylmethylsulfonyl fluoride (lysis
buffer) and incubated at 4 °C for 10 min. RBC ghosts were washed three times
by centrifugation (20,000×g for 20 min at 4 °C) to obtain “white” ghosts [31].
For the preparation of “cytoskeleton-bound” and “unbound” protein
fractions [31], aliquots of washed ghosts were mixed with an equal volume of
0.5% octaethylene glycol n-dodecyl monoether (C12E8) in the lysis buffer, and
left on ice for 10 min. The detergent extracts were layered over a cushion of 35%
sucrose, 0.5% C12E8 in lysis buffer and centrifuged at 20,000×g for 90 min and
4 °C. The resulting pellet contained the detergent insoluble protein fraction
(termed “cytoskeleton-bound”) whereas the supernatant contained the soluble
protein fraction (termed “unbound”). Aliquots from RBC ghosts, “cytoskeleton-
bound” and “unbound” fractions were solubilized in 5% SDS. Protein
concentration was determined by using the micro bicinchoninic acid assay,
and equal amounts (15 μg) of protein were loaded per lane of each gel.
Electrophoresis was performed according to the method of Fairbanks [32] using
5.6% polyacrylamide gels containing 1% SDS.
2.4. Western blot analyses
Samples were transferred to Hybond ECL nitrocellulose (Amersham).
Nonspecific binding sites were blocked by incubating the nitrocellulose
membrane in SuperBlock T-20 (Bio Rad) for 1 h at room temperature prior to
the addition of antibodies then incubated with either anti-phosphotyrosine
antibody clone 4G10 (Upstate) diluted to a final concentration of 1.5 μg/ml, or
anti-band 3 antibody (Alpha Diagnostics Inc) diluted to a final concentration of
0.5 μg/ml in SuperBlock T-20 overnight at 4 °C. Membranes were washed 3
times with Tris Buffered Saline containing 0.1% Tween 20 and then incubated
with the appropriate horseradish peroxidase conjugated secondary antibody
diluted in SuperBlock T-20. Finally the membranes were incubated with West
Pico chemiluminescence reagent (Pierce) and exposed to X-ray film.
2.5. Sulfate uptake and incubations
The anion transport activity was measured as described by Jarolim et al.
[33]. Washed RBCs were subjected to three additional washes in 84 mM
trisodium citrate, 1 mM EGTA, pH 6.5 buffer. Cells were resuspended to a
hematocrit of 50%. The cell suspension was mixed 1:1 with 4 mM sodium
sulfate, 84 mM sodium citrate, and 1 mM EGTA at pH 6.5 containing 6 μCi of
disodium [35]S sulfate (ICN Biomedicals). Samples were incubated at 26 °C and
aliquots were taken at 5, 10, 15, and 20 min of incubation. The band-3 specific
anion transport inhibitor 4,4′-diisothiocyano-4,4′-diisothiocyanostilbene-2,2′-
disulfonic acid DIDS, (Calbiochem) was administered 10 min prior to initiating
the incubation with the radioactive tracer. Maximum inhibitory DIDS
concentration was calculated by linear regression analysis of inhibitory curves.
For studies using pervanadate, cell suspensions were pre-incubated with
pervanadate (0.5, 1 and 2 mM) or vehicle for 10 min at 26 °C prior to initiating
cell extractions for Western blotting, incubation with the radioactive tracer or
testing RBC for cell deformability.
2.6. Determination of RBC deformability
RBC deformability was analyzed with a laser-assisted ektacytometer
(LORCA) as previously described [26]. Briefly, an aliquot containing
approximately 30 million RBCs was suspended in 1 ml of 5% polyvinylpyrro-
lidone (mol wt 360,000; Sigma, St. Louis, MO) in PBS at a final viscosity of
30 mPa. After gently mixing for 15 min at room temperature, cell deformability
was determined at 37 °C. Cell deformability was assessed by calculating the
elongation index (EI) at shear stresses ranging from 0.3 to 30 Pa as described
previously [26].
2.7. Flow cytometry
EMA, (eosin-5-maleimide) was added to heparinized whole blood at a final
concentration of 0.3 mg/ml and incubated at room temperature for 1 h in the
Fig. 1. Relationship of band-3 tyrosine phosphorylation, RBC deformability, and sulfate uptake. RBCs were incubated in the absence or presence of pervanadate (0–
2.0 mM) and tested for protein tyrosine phosphorylation, cell deformability and sulfate uptake as described in Materials and methods. (A) protein extracts from RBC
ghosts were subjected to SDS polyacrylamide electrophoresis and probed with anti phospho-tyrosine antibody (Panel A upper row) or band-3 content using an anti rat
band-3 antibody (Panel A lower row). (B) RBC elongation in response to increasing shear stress in the presence of pervanadate (2.0 mM). (C) time dependence of
sulfate uptake and the effect of DIDS (10 μM). (D) the effect of pervanadate (2.0 mM) on RBC sulfate uptake. Mean±SEM, from 3 to 6 independent assays,
⁎significant difference compared to vehicle.
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twice with 500 μl of PBS containing 0.5% BSA. Samples are analyzed by a
Fluorescence Activated Cell Sorter (FACS-Caliber, Becton-Dickinson, CA, and
USA). Cell gating was set to include only RBCs (exclude white blood cells and
lymphocytes). After excitation at 488 nm, green fluorescence of gated RBC
(15,000 events) were collected and analyzed [34].
2.8. Reagents
When applicable, cell culture grade buffers, media and reagents were used.
Hank's Balanced Salt Solution, without phenol red, and Dulbecco's Phosphate
Buffered Saline were purchased from Life Technologies, Grand Island, NY.
Buffers were sterile filtered and de-gassed before use.Fig. 2. Sepsis increases band-3 tyrosine phosphorylation in RBCs. RBC ghosts obtain
PAGE and analyzed for band-3 content using antibodies against band-3 (A) or tyrosi
was normalized to total band-3 content obtained in the same lane for each fraction (PY
difference compared to control. (C) depicts a typical finding in ghosts (lane 1), unbo
animals as indicated.2.9. Statistical analysis
Statistical calculations were performed using JMP software (SAS Institute
Inc., Cary, NC). Results were analyzed using ANOVA followed by t-test for
pair-wise comparisons or Tukey–Kramer's test for multiple comparisons. Data
are expressed as mean±SE. Statistically significant difference was concluded at
p<0.05.
3. Results
First, in a series of in vitro experiments, we tested the
relationship among RBC band-3 tyrosine phosphorylationed from control and septic mice were sub-fractionated and then subjected to SDS
ne-phosphorylated proteins (B). The intensity of tyrosine phosphorylated band 3
B3/B3). Mean±SEM from 6 to 8 animals in each treatment group. ⁎Significant
und (lane 2) and cytoskeleton-bound (lane 3) fractions from control and septic
Fig. 3. Anion transport in RBCs from septic mice. Sulfate uptake in RBCs from
control and septic mice was determined as described in Materials and methods.
Time course of sulfate uptake in RBCs (A) and the effect of prevailing
concentration of DIDS (B) in RBCs from control and septic mice are shown.
Extrapolation of the DIDS inhibitory curve indicates an intercept with the X-axis
approximately at 2.5 μM in both control and septic animals (dotted line). Mean±
SEM from 3 animals in each group.
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unchallenged animals were isolated and incubated with
pervanadate that increases tyrosine phosphorylation by inhibit-
ing tyrosine phosphatases. After the treatments, cells were
processed and analyzed for protein tyrosine phosphorylation,
cell deformability and sulfate uptake in parallel. Fig. 1A shows
that in the absence of pervanadate (vehicle), band-3 tyrosine
phosphorylation was below detection limit (but was measurable
after longer exposures) as determined by anti-phospho-tyrosine
antibody staining in RBC ghosts (Fig. 1A lane 1, upper row).
Pervanadate treatment resulted in a marked and concentration
dependent increase in band-3 tyrosine phosphorylation (Fig. 1A
lanes 2–4 upper row). Fig. 1A lower row indicates band-3
content in each lane as determined by re-probing the
membranes by anti-band-3 antibody. Testing the effect on
RBC elongation in response to prevailing sheer stress indicated
decreased cell deformability in the presence of pervanadate as
compared to vehicle-treated controls (Fig. 1B). Fig. 1C
indicates that RBC sulfate uptake was time dependent and
DIDS, a known inhibitor of band-3 dependent anion exchange,
almost completely inhibited sulfate uptake. Pervanadate treat-Fig. 4. Comparison of band-3 tyrosine phosphorylation betweenWTand G6PDmutan
was compared between WT and G6PD deficient animals. RBC ghost and cell fracti
band-3 antibody; (B) indicates tyrosine-phosphorylated band-3. Mean±SEM from
#compared to WT septic.ment inhibited sulfate uptake as compared to vehicle-treated
controls (Fig. 1D). Whereas pervanadate may influence other
cellular functions, these in vitro observations suggested an
association between elevated band-3 tyrosine phosphorylation
and decreases in RBC deformability and anion transport
activity.
Since studies have shown decreased RBC deformability
during sepsis, in the next series of experiments, we tested
whether the septic condition also increases band-3 tyrosine
phosphorylation status and whether this condition was asso-
ciated with changes in anion transport activity. RBCs were
collected from septic (24 h) and control (untreated) animals and
processed for protein analyses in RBC ghosts (total band-3) as
well as in detergent insoluble (cytoskeleton-bound) and
detergent soluble (unbound) fractions. Fig. 2A shows that
band-3 content was similar between septic and control animals
in RBC ghosts as well as RBC detergent extracts. In contrast,
band-3 tyrosine phosphorylation (normalized to band-3 content
in each prep) was markedly increased in all RBC fractions from
septic animals compared to controls (Fig. 2B). A representative
finding of Western blot analyses is shown in Fig. 2C. Probing
RBC protein extracts for serine phosphorylation from septic and
control animals showed no remarkable increase in band-3
tyrosine phosphorylation after sepsis (data not shown).
Comparison of sulfate uptake in RBCs from septic and
control animals revealed no differences in anion exchange
activity (Fig. 3A). Furthermore, the DIDS-induced inhibitory
curves of sulfate uptake showed similar kinetics between septic
and control animals (Fig. 3B). Extrapolation of the inhibitory
curve resulted in the same maximal inhibitory concentration of
DIDS at approximately 2.5 μM under septic and control
conditions.
Glucose-6-phosphate dehydrogenase (G6PD) is a key
antioxidant enzyme in RBCs [35]. Because oxidative stress
has been implicated in causing RBC dysfunction during sepsis,
and the decrease in RBC deformability was more pronounced
in septic G6PD deficient than WT animals [25], in the next
series of experiments, we compared the sepsis-induced
changes in band-3 tyrosine phosphorylation between G6PD
mutant and WT animals. Fig. 4A indicates that band-3 contentt animals. In separate sets of experiments band-3 tyrosine phosphorylation status
ons were analyzed as described for Fig. 2. (A) shows results after probing with
6 animals in each group. Significant difference, ⁎compared to WT control;
Fig. 5. Band-3 EMA reactivity in RBCs.Whole RBC suspensions were prepared
from control and septic; WT and G6PD deficient animals and incubated in the
presence of EMA followed by flow cytometry analysis as described in Materials
and methods. (A) summary of results from five animals in each group, mean±
SEM. (B) shows a representative finding. ⁎Significant difference compared to
WT control.
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fractions of septic G6PD deficient animals as compared to WT.
However, the sepsis-induced increase in band-3 tyrosine
phosphorylation was less pronounced in G6PD deficient
animals as compared to WT especially in the cytoskeleton-
bound fraction of band-3 (Fig. 4B). Anion exchange activity as
assessed by sulfate uptake was similar in RBCs from G6PD
deficient and WT animals either under control or septic
conditions (data not shown).Elevated band-3 tyrosine phosphorylation may affect band-3
organization within the RBCmembrane. To test this question on
freshly isolated RBCs, we compared the reactivity of band-3
with the fluorescent dye (EMA) that binds to lysine located at
one of the extracellular loops of band-3. Cells from WT and
G6PD deficient animals under control or septic conditions were
collected and analyzed ex vivo using flow cytometry. Fig. 5A
shows that sepsis resulted in increased RBC EMA fluorescence
in WT animals. Comparison of RBCs from G6PD deficient and
WT animals under control conditions indicated greater EMA
fluorescence in G6PD deficiency compared to WT however,
sepsis caused no additional increase in EMA-fluorescence in
G6PD deficient RBCs.
4. Discussion
This study reports that polymicrobial sepsis results in
elevated band-3 tyrosine phosphorylation in circulating RBCs.
This observation suggests that increased band-3 tyrosine
phosphorylation may represent one of the underlying mechan-
isms contributing to RBC dysfunction during inflammatory
conditions. Based on in vitro observations, band-3 tyrosine
phosphorylation has been implicated in the regulation of RBC
anion exchange activity [20–22]. We also observed an
association between increased band-3 tyrosine phosphorylation
and decreased anion exchange in vitro; however, we found that
band-3 tyrosine phosphorylation was not accompanied by
altered RBC sulfate uptake following in vivo sepsis. This
indicates that other factors, besides band-3 tyrosine phosphor-
ylation, are required for modulating RBC anion exchange
activity in vivo, or repair mechanisms exist under in vivo
conditions that are absent following the employed irreversible
pharmacological challenge in vitro.
Studies have indicated that hypoxia increases band-3
tyrosine phosphorylation in vitro [36]. Because impaired
oxygen exchange in the lung and peripheral tissues is prevalent
during sepsis, it is possible that the observed elevation in band-3
tyrosine phosphorylation is associated with decreased RBC
oxygenation in this model. It also remains a question whether an
elevated band-3 tyrosine phosphorylation is part of the
pathology leading to RBC dysfunction during sepsis or
alternatively, it is a compensatory event that is part of the
cellular defense mechanism under inflammatory conditions.
The fact that elevated band-3 tyrosine phosphorylation was
shown to stimulate glucose utilization by RBCs supports
potential beneficial effects [12]. It remains to be tested whether
pharmacological stimulation or inhibition of band-3 tyrosine
phosphorylation worsens or alleviates RBC pathology follow-
ing inflammation.
It has been demonstrated by independent investigations that
RBC deformability is decreased during sepsis and endotox-
emia [4,6,25,26,37]. The biochemical mechanism responsible
for this increased RBC membrane rigidity has not yet been
elucidated. However, several studies demonstrated that inter-
actions between band-3 and the cytoskeletal spectrin/actin
network play an important function in the maintenance of
normal RBC shape and membrane structure [31,38]. Our
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in RBC ghosts as well as cytoskeletal-bound and unbound
fractions suggests that the tyrosine phosphorylation event does
not result in grossly increased binding affinity of band-3 to the
cytoskeletal network. However, although the employed
detergent based RBC fractionation method is commonly
used, this procedure might have interrupted weaker interac-
tions between band-3 and the cytoskeletal network. Thus, it
remains possible that sepsis-induced tyrosine phosphorylation
promotes fine associations between band-3 and the cytoske-
letal network. A different organization of band-3 in RBC
membranes following sepsis is further supported by the
observation that the reactivity of band-3 with EMA was
markedly increased after the septic challenge. Although EMA
binds to lysine located in the extracellular portion of band-3,
the sepsis-induced increase in EMA reactivity may reflect
conformational change of band-3 due to altered interactions
with the cytoskeletal anchoring proteins as well as changes in
band-3 glycosylation status.
Oxidative stress is an important component of sepsis
pathology and has been implicated in cellular and organ
dysfunction following inflammation [39]. Likewise, antiox-
idant therapy prevented infection-induced decrease in RBC
deformability in animal models in vivo [40,41]. In the
employed model, we demonstrated earlier that sepsis
increased plasma glutathione levels and oxidized glutathione
content in RBCs, whereas in vivo antioxidant treatment by N-
acetyl-cysteine alleviated sepsis-induced decrease in RBC
deformability [25]. Therefore, in order to investigate the
potential involvement of oxidative stress in causing elevated
band-3 tyrosine phosphorylation, we utilized a G6PD mutant
mouse model that displays a partial G6PD deficiency (20% of
normal) similar to that observed in the common type-III
human G6PD deficiencies [25,35]. We found elevated band-3
abundance in RBCs from G6PD mutant animals compared to
WT that is presumably associated with increased RBC
turnover in G6PD deficiency consistent with earlier observa-
tions in humans [42] and this mouse model [25]. The fact that
band-3 reactivity with the fluorescent dye was also elevated
in G6PD deficient cells compared to WT under control as
well as septic conditions further supports an altered band-3
status in G6PD deficiency. However, somewhat unexpectedly
we found a lessened degree of band-3 tyrosine phosphoryla-
tion, especially in the cytoskeleton-bound fraction, in G6PD
deficient cells compared to WT under septic conditions. These
observations clearly indicate that G6PD deficiency modulates
sepsis-induced RBC responses, however, the findings suggest
complex mechanistic differences between G6PD deficient and
WT animals rather than simple augmentation of sepsis-
induced changes.
In vitro studies demonstrated that hyperosmotic stress [43–
45] promotes band-3 tyrosine phosphorylation in RBCs. The
fact that RBC mean corpuscular volume (MCV) was shown to
be similar in WT as well as deficient animals either under
control or septic conditions [25,26] suggest that RBC volume
alterations do not play a major role in the sepsis-induced
increase in band-3 tyrosine phosphorylation or account for theobserved baseline differences between WT and G6PD deficient
animals. It has also been demonstrated that in vitro-stimulated
Ca2+ influx augments band-3 tyrosine phosphorylation in RBCs
[46–48]. It remains to be elucidated whether subtle changes in
RBC Ca2+ metabolism under septic conditions contribute to the
increase in band-3 tyrosine phosphorylation or whether
differences in Ca2+ homeostasis play a role in modulating
band-3 tyrosine phosphorylation in G6PD deficient animals.
In summary, we presented evidence that sepsis is accom-
panied by increased band-3 tyrosine phosphorylation and
potential alterations in band-3 membrane organization without
compromising anion exchange activity in RBCs. Partial G6PD
deficiency is accompanied by altered band-3 status but it does
not augment band-3 tyrosine phosphorylation following sepsis.
Under septic conditions, elevated band-3 tyrosine phosphoryla-
tion may be associated with decreased RBC deformability or
disturbed metabolic status or it may represent a compensatory
defensive mechanism supporting RBC functions.
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